Bellevue Asset Management, manager of the BB Biotech trust, is to expand its range with the launch of a broader healthcare investment trust today.
Zurich-based Bellevue has $4bn invested in the healthcare industry and is seeking to raise £200m for the new trust. It will be a high conviction, long-only investment trust invested in listed or quoted...
To continue reading this article...
Join Investment week
- Unlimited access to real-time news, analysis and opinion from the investment industry, including the Sustainable Hub covering fund news from the ESG space
- Get ahead of regulatory and technological changes affecting fund management
- Important and breaking news stories selected by the editors delivered straight to your inbox each day
- Weekly members-only newsletter with exclusive opinion pieces from leading industry experts
- Be the first to hear about our extensive events schedule and awards programmes
